We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

88 hedge funds and large institutions have $136M invested in Korro Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $1.2M

0.05% less ownership

Funds ownership: 1.14% → 1.09% (-0.05%)

3% less funds holding

Funds holding: 91 → 88 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

28% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 32

32% less capital invested

Capital invested by funds: $199M → $136M (-$63.2M)

Holders
88
Holders Change
-3
Holders Change %
-3.3%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
32
Closed
12
Calls
$1.54M
Puts
$1.2M
Net Calls
+$334K
Net Calls Change
-$420K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$4.13M
2
BlackRock
BlackRock
New York
+$953K
3
GCP
GSA Capital Partners
United Kingdom
+$643K
4
SDIC
South Dakota Investment Council
South Dakota
+$513K
5
Walleye Capital
Walleye Capital
New York
+$416K

Top Sellers

Rank Fund Capital Flow
1
Amundi
Amundi
France
-$3.93M
2
SFM
Sphera Funds Management
Israel
-$2.74M
3
Millennium Management
Millennium Management
New York
-$1.88M
4
Morgan Stanley
Morgan Stanley
New York
-$1.46M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.27M

KRRO Hedge Fund Activity: Q3 2021 in Review

88 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2021, worth a combined $136M — down 32% from $199M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of KRRO and 9 opened new positions — a net loss of 3 holders — while 32 trimmed existing stakes and 23 added.

The largest buyer was Federated Hermes, adding an estimated $4.13M. The largest seller was Amundi, cutting an estimated $3.93M.

  • 88 institutional investors held Korro Bio (KRRO) as of Q3 2021, down from 91 in Q2 2021.
  • Funds reported $136M of Korro Bio stock for Q3 2021, down 32% quarter-over-quarter.
  • 9 funds opened new Korro Bio positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest Korro Bio buyer in Q3 2021 was Federated Hermes, an estimated $4.13M added.
  • The largest Korro Bio seller in Q3 2021 was Amundi, an estimated $3.93M sold.

Based on aggregated 13F filings for Q3 2021.